The US Food and Drug Administration named Dexcom as the first manufacturer selected for its Technology-Enabled Meaningful Patient Outcomes pilot on Tuesday. The programme, known as TEMPO, allows digital health devices to be offered to Med
Pressure lows are a known thing. I recently learned there is a new type of device that lasts 365 days, but it involves surgically inserting the sensor under the skin and removing it at the end. The sensor is then powered by a rechargeable external device. They claim this technique is basically immune to compression lows.
But this isn’t available over the counter, and requires a specific diagnosis to qualify.
Yeah I was looking at that. But I have prediabetes / insulin resistance, and in my local area, nobody cares until your pancreas completely kicks the bucket. Prevention of disease isn’t really a thing here. That’s why I went out and bought my own sensor, just to see what was going on. It was useful for seeing like, wait why did my blood sugar spike after breakfast? Oh I didn’t realise overcooked oats were high gi. I changed it to raw oats in warm milk which is much smoother on the graph. But I would never qualify for that device because my problems don’t show up on the 3 month A1C test. And after I optimised the 3 foods that were more spike-y than the rest, I had no use for the inaccurate glucose monitor.
I’m glad you got some feedback out of it. I think that’s where they have the most value right now. But they are too expensive and too inconsistent for the sort of mass rollout RFK wants here in the US. They need to improve a lot to move away from the style of use you got out of an OTC version.
Pressure lows are a known thing. I recently learned there is a new type of device that lasts 365 days, but it involves surgically inserting the sensor under the skin and removing it at the end. The sensor is then powered by a rechargeable external device. They claim this technique is basically immune to compression lows.
But this isn’t available over the counter, and requires a specific diagnosis to qualify.
Yeah I was looking at that. But I have prediabetes / insulin resistance, and in my local area, nobody cares until your pancreas completely kicks the bucket. Prevention of disease isn’t really a thing here. That’s why I went out and bought my own sensor, just to see what was going on. It was useful for seeing like, wait why did my blood sugar spike after breakfast? Oh I didn’t realise overcooked oats were high gi. I changed it to raw oats in warm milk which is much smoother on the graph. But I would never qualify for that device because my problems don’t show up on the 3 month A1C test. And after I optimised the 3 foods that were more spike-y than the rest, I had no use for the inaccurate glucose monitor.
I’m glad you got some feedback out of it. I think that’s where they have the most value right now. But they are too expensive and too inconsistent for the sort of mass rollout RFK wants here in the US. They need to improve a lot to move away from the style of use you got out of an OTC version.